{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:24:42Z","timestamp":1795008282727,"version":"4.9.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To assess the efficacy and safety of intentional watch and wait (W&amp;W) and organ preservation surgery following neoadjuvant chemoradiotherapy plus consolidation CAPEOX in magnetic resonance imaging (MRI)-defined low-risk rectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Clinical T2\/early T3 rectal cancers can achieve high yield pathological complete response (ypCR) rates after chemoradiotherapy; thus, an intentional W&amp;W or organ preservation strategy for good clinical responders in these subgroups can be further tested.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This prospective, single-arm, phase 2 trial enrolled patients with low-risk MRI prestaged rectal cancers, who concurrently received chemoradiation, followed by four 3-weekly cycles of CAPEOX regimen. Following reassessment, clinical complete response (cCR) or near-cCR patients underwent W&amp;W\/organ preservation surgery; the primary endpoint was a 3-year organ preservation rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 64 participants, 58 completed treatment, with 6.4% and 33.9% grade 3 to 4 toxicities in the radiotherapy and consolidation CAPEOX phases, respectively, during a median 39.5-month follow-up. Initial cCR, and non-cCR occurred in 33, 13, and 18 patients, respectively. Of the 31 cCR and 7 near-cCR cases managed by W&amp;W, local regrowth occurred in 7; of these, 6 received salvage surgery. The estimated 2-year local regrowth rates were 12.9% [95% confidence interval (CI): 1.1%\u201324.7%] in cCR and 42.9% (95% CI: 6.2%\u201379.6%) in near-cCR cases, respectively. Eight patients received local excision, including 2 with regrowth salvage. Lung metastases occurred in 3 patients and multiple metastasis occurred in 1 patient; no local recurrence occurred. The estimated 3-year organ preservation rate was 67.2% (95% CI: 55.6%\u201378.8%). The estimated 3-year cancer-specific survival, non-regrowth disease-free survival, and stoma-free survival were 96.6% (95% CI: 92.1%\u2013100%), 92.2% (95% CI: 85.5%\u201398.9%), and 82.7% (95% CI: 73.5%\u201391.9%), respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Chemoradiotherapy plus consolidation CAPEOX for MRI-defined low-risk rectal cancer can lead to high rates of organ preservation through intentional W&amp;W or local excision. The oncologic safety of this strategy should be further tested.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sla.0000000000005507","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T08:12:02Z","timestamp":1656490322000},"page":"647-654","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":42,"title":["Intentional Watch and Wait or Organ Preservation Surgery Following Neoadjuvant Chemoradiotherapy Plus Consolidation CAPEOX for MRI-defined Low-risk Rectal Cancer"],"prefix":"10.1097","volume":"277","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, Peking University Cancer Hospital, Beijing, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Peking University Cancer Hospital, Beijing, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ming","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Peking University Cancer Hospital, Beijing, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Jie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endoscopy Center, Peking University Cancer Hospital, Beijing, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Wu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Peking University Cancer Hospital, Beijing, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Shi","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Radiology, Peking University Cancer Hospital, Beijing, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hu","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Wen","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Peking University Cancer Hospital, Beijing, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of The Rectal Cancer Cooperative Group of Peking University Cancer Hospital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"R1-20250424","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"key":"R2-20250424","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"van Gijn","year":"2011","journal-title":"Lancet Oncol"},{"key":"R3-20250424","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"key":"R4-20250424","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S2468-1253(18)30301-7","article-title":"Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis","volume":"3","author":"Chadi","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R5-20250424","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(15)00467-2","article-title":"Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis","volume":"17","author":"Renehan","year":"2016","journal-title":"Lancet Oncol"},{"key":"R6-20250424","doi-asserted-by":"crossref","first-page":"e185896","DOI":"10.1001\/jamaoncol.2018.5896","article-title":"Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy","volume":"5","author":"Smith","year":"2019","journal-title":"JAMA Oncol"},{"key":"R7-20250424","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/SLA.0000000000002761","article-title":"Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis","volume":"268","author":"Dattani","year":"2018","journal-title":"Ann Surg"},{"key":"R8-20250424","doi-asserted-by":"crossref","first-page":"e180071","DOI":"10.1001\/jamaoncol.2018.0071","article-title":"Adoption of total neoadjuvant therapy for locally advanced rectal cancer","volume":"4","author":"Cercek","year":"2018","journal-title":"JAMA Oncol"},{"key":"R9-20250424","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1245\/s10434-017-5841-3","article-title":"Nonoperative management or \u2018watch and wait\u2019 for rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy: a critical appraisal","volume":"24","author":"Sammour","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R10-20250424","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/SLA.0b013e31820b8d52","article-title":"Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European Study that recruited consecutive patients with rectal cancer","volume":"253","author":"Taylor","year":"2011","journal-title":"Ann Surg"},{"key":"R11-20250424","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/DCR.0000000000000564","article-title":"Complete pathological response after neoadjuvant long-course chemoradiotherapy for rectal cancer and its relationship to the degree of T3 mesorectal invasion","volume":"59","author":"Wilkins","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"R12-20250424","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/DCR.0000000000000294","article-title":"Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer","volume":"58","author":"Wang","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"R13-20250424","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1186\/s12885-015-1632-z","article-title":"Organ preservation in rectal adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management","volume":"15","author":"Smith","year":"2015","journal-title":"BMC Cancer"},{"key":"R15-20250424","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1016\/S1470-2045(20)30024-3","article-title":"Outcome measures in multimodal rectal cancer trials","volume":"21","author":"Fokas","year":"2020","journal-title":"Lancet Oncol"},{"key":"R16-20250424","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(20)30557-X","article-title":"Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study","volume":"22","author":"Fernandez","year":"2021","journal-title":"Lancet Oncol"},{"key":"R17-20250424","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/DCR.0000000000000558","article-title":"Pathologic complete response in rectal cancer: can we detect it? Lessons learned from a proposed randomized trial of watch-and-wait treatment of rectal cancer","volume":"59","author":"Nahas","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"R18-20250424","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2015.04.003","article-title":"Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12\/PRODIGE 2 randomized trial","volume":"115","author":"Gerard","year":"2015","journal-title":"Radiother Oncol"},{"key":"R19-20250424","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/DCR.0b013e3182837e5b","article-title":"Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer","volume":"56","author":"Huh","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"R20-20250424","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.radonc.2021.05.014","article-title":"Watch-and-wait strategy in rectal cancer: is there a tumour size limit? Results from two pooled prospective studies","volume":"160","author":"Jankowski","year":"2021","journal-title":"Radiother Oncol"},{"key":"R21-20250424","doi-asserted-by":"crossref","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones","year":"2018","journal-title":"Ann Oncol"},{"key":"R22-20250424","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/SLA.0000000000002447","article-title":"Organ preservation in cT2N0 rectal cancer after neoadjuvant chemoradiation therapy: the impact of radiation therapy dose-escalation and consolidation chemotherapy","volume":"269","author":"Habr-Gama","year":"2019","journal-title":"Ann Surg"},{"key":"R23-20250424","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1148\/radiol.2018172889","article-title":"MRI of extramural venous invasion in locally advanced rectal cancer: relationship to tumor recurrence and overall survival","volume":"289","author":"Zhang","year":"2018","journal-title":"Radiology"},{"key":"R24-20250424","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/bjc.2013.603","article-title":"Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer","volume":"110","author":"Chand","year":"2014","journal-title":"Br J Cancer"},{"key":"R25-20250424","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1308\/rcsann.2019.0018","article-title":"Systematic review and meta-analysis on outcomes of salvage therapy in patients with tumour recurrence during \u2018watch and wait\u2019 in rectal cancer","volume":"101","author":"On","year":"2019","journal-title":"Ann R Coll Surg Engl"},{"key":"R26-20250424","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S2468-1253(18)30309-1","article-title":"Watch and wait in rectal cancer: is it time to subclassify cT3?","volume":"3","author":"Glynne-Jones","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R27-20250424","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","article-title":"Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial","volume":"16","author":"Garcia-Aguilar","year":"2015","journal-title":"Lancet Oncol"},{"key":"R28-20250424","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/DCR.0000000000000280","article-title":"Simulating watch and wait for rectal cancer","volume":"58","author":"Chang","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"R29-20250424","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00384-015-2165-2","article-title":"Surveillance after neoadjuvant therapy in advanced rectal cancer with complete clinical response can have comparable outcomes to total mesorectal excision","volume":"30","author":"Smith","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"R30-20250424","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/DCR.0000000000001018","article-title":"Quality of life in patients with rectal cancer after chemoradiation: watch-and-wait policy versus standard resection-are we comparing apples to oranges?","volume":"61","author":"Vailati","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"R31-20250424","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1245\/s10434-021-09827-w","article-title":"Endoscopic feature and response reproducibility in tumor assessment after neoadjuvant therapy for rectal adenocarcinoma","volume":"28","author":"Felder","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"R32-20250424","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/DCR.0b013e3182a25c4e","article-title":"Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?","volume":"56","author":"Habr-Gama","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"R33-20250424","doi-asserted-by":"crossref","first-page":"e019474","DOI":"10.1136\/bmjopen-2017-019474","article-title":"Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study","volume":"7","author":"Rombouts","year":"2017","journal-title":"BMJ Open"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000005507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T21:08:54Z","timestamp":1745442534000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000005507"}},"subtitle":["Findings From a Prospective Phase 2 Trial (PKUCH-R01 Trial, NCT02860234)"],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000005507","relation":{},"ISSN":["0003-4932"],"issn-type":[{"value":"0003-4932","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,29]]}}}